Physician profile
Jaime Cepeda
NPI 1811932965
$46,261.09
in general payments reported to CMS, 2019-2025
15 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $20K · 2021: $5,191 · 2022: $2,857 · 2023: $5,150 · 2024: $63.28 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,337 · Food and Beverage: $774 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,336.92 |
| Food and Beverage | $774.43 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $28,924.32 | 2019-2020 | |
| Applied Medical Resources Corporation | $10,327.86 | 2019-2023 | |
| Intuitive Surgical, INC. | $3,285.82 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Apollo Endosurgery US INC | $2,593.80 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Stryker Corporation | $445.19 | 2022 | |
| Merck Sharp & Dohme LLC | $144.95 | 2019-2025 | Bridion |
| Smith+Nephew, INC. | $133.32 | 2021 | |
| Novo Nordisk INC | $124.99 | 2023 | Wegovy |
| Teleflex LLC | $88.33 | 2025 | Titan Sgs Bailout Chuck |
| Davol INC. | $75.35 | 2021-2024 | Phasix Mesh |
| Medtronic, INC. | $45.88 | 2023 | Ligasure |
| Bausch & Lomb Americas INC. | $21.81 | 2025 | Stellaris |
| Lilly USA, LLC | $19.84 | 2023 | Zepbound |
| Reprise Biomedical, INC. | $15.98 | 2025 | Miro3d |
| Convatec INC. | $13.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Cepeda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.